Give me a share of that■ Q&M associate Aoxin has proposed to acquire 49% of Acumen Diagnostics.Purchase consideration is S$29.4m via issuance of new ordinary shares.■ Post-acquisition, Q&M will hold a c.33% effective stake in Aoxin (vs. 44%now). Acquisition to be completed within six months of announcement date.■ We estimate c.8% FY22F EPS accretion as […]

Read more of this post